About Jacqueline Iversen
Form D filings for Sen-Jam Pharmaceutical from 2023 to 2024 list Jacqueline Iversen as executive officer.
Jacqueline Iversen first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jacqueline Iversen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jacqueline Iversen works with at each company, as listed on that company's latest Form D.
Sen-Jam Pharmaceutical Inc. · Form D/A, Jul 25, 2024
JI
James Iversen
Executive officer and director